ACALABRUTINIB

12744 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking ACALABRUTINIB:

# Side effect Count
0 DEATH 2186
1 FATIGUE 725
2 HEADACHE 657
3 PRODUCT DOSE OMISSION ISSUE 522
4 DIARRHOEA 443
5 FALL 395
6 DYSPNOEA 352
7 CONTUSION 351
8 PNEUMONIA 337
9 MALIGNANT NEOPLASM PROGRESSION 325
See all common reactions for ACALABRUTINIB

ACALABRUTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DERMATOPOROSIS 4 0.3333
1 SPLEEN ATROPHY 10 0.1695
2 ORAL MUCOSA HAEMATOMA 6 0.0822
3 ACINETOBACTER SEPSIS 5 0.0781
4 LEUKAEMIC INFILTRATION 10 0.0714
5 RETICULOCYTOPENIA 10 0.0685
6 MANTLE CELL LYMPHOMA RECURRENT 26 0.0598
7 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 36 0.0516
8 HAEMATOTYMPANUM 4 0.0471
9 ORAL BLOOD BLISTER 7 0.0350
See all enriched reactions for ACALABRUTINIB